SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K, dated March 10, 2020, is a current report filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc., as noted in the request metadata). The filing serves to announce the Company's financial results for the three months and the full year ended December 31, 2019. The report is signed by Andrew Jackson, Interim Chief Executive Officer and Chief Financial Officer.
Key Financial Metrics
The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the body of this 8-K.
Material Changes
The filing does not explicitly list material changes versus prior periods within the text provided. It directs readers to the attached press release (Exhibit 99.1) for the comparative financial analysis and operational updates for the period ended December 31, 2019.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, and specific risk factors are contained within the referenced press release (Exhibit 99.1). The 8-K text notes that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other documents unless expressly stated.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the quarter and year ended December 31, 2019, by reviewing Exhibit 99.1 (Press Release).
- Confirm the status of the Interim CEO/CFO leadership and any transition plans mentioned in the press release.
- Review the press release for any updated financial guidance or outlook for 2020.
- Check for any unusual items or contingencies disclosed in the full press release text.